Efficacy of Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results from the Phase 3 DISCREET Trial

Main Article Content

Joseph F. Merola
Lawrence Charles Parish
Lyn Guenther
Charles Lynde
Jean-Philippe Lacour
Petra Staubach
Sue Cheng
Cynthia Deignan
Mindy Chen
Kim A. Papp
Dawn Nicewarner


apremilast, efficacy, safety, moderate to severe, genital psoriasis, systemic


1. Schmid-Ott G, et al. Acta Derm Venereol. 1999;79:443-447. 2. Meeuwis KA, et al. Dermatology. 2012;224:271-276. 3. Ryan C, et al. J Am Acad Dermatol. 2015;72:978-983. 4. Meeuwis KA, et al. Derm Venereol. 2011;915-911

Most read articles by the same author(s)

1 2 3 4 > >>